Skip to main content
. 2022 Aug 4;10(8):449. doi: 10.3390/toxics10080449

Figure 3.

Figure 3

Identified connections between outcomes of epidemiological, in vivo, and in vitro studies on per- and polyfluoroalkyl substances (PFAS) and adverse outcome pathways (AOPs) from AOP-Wiki with a focus on the components of metabolic syndrome.